Benitec Wins US Patent Allowance, Says Separate IP Re-exam Likely to Extend into Late 2010
September 03, 2009
Benitec Wins US Patent Allowance, Says Separate IP Re-exam Likely to Extend into Late 2010
The allowed patent covers the use of multiple-promoter expression cassettes for simultaneous delivery of RNAi. Separately, the Aussie shop said the USPTO won’t likely decide a company appeal until the third quarter of next year.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Benitec Says USPTO Poised to Finalize Validity Ruling for Key Patent
February 17, 2011 / Gene Silencing News - Benitec Looks to Outlicense IP While Avoiding Litigation Mistakes of Its Past
November 8, 2012 / Gene Silencing News - Re-Exam of Benitec US Patent Ends, Company Hits Opposition in UK
November 11, 2010 / Gene Silencing News - Benitec Says USPTO Reverses Rejection of US Patent
September 30, 2010 / Gene Silencing News - Patents Held by Benitec, Collaborator Allowed in US, South Korea, China
April 4, 2013 / Gene Silencing News